Bausch Health Companies share price logo

Bausch Health Companies

NYSE: BHC

Mid Cap

$5.64

-0.03

(-0.53%)

as on

Bausch Health Companies Stock Performance

as on September 22, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $5.55
    $5.70
    downward going graph

    1.60%

    Downside

    1.06%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.33
    $8.00
    downward going graph

    23.23%

    Downside

    41.84%

    Upside

    downward going graph

Bausch Health Companies share price movements today

Previous Close
$5.67
Open
$5.64
Volume
1.4M
Market Cap
$2.1B
Day's Low - High
$5.55 - $5.70
52 Week Low - High
$4.33 - $8.00

Bausch Health Companies Historical Returns

1 Month Return
-11.96 %
3 Month Return
+ 18.87 %
1 Year Return
-15.75 %
3 Year Return
-32.42 %
5 Year Return
-79.9 %

Bausch Health Companies Stock Fundamentals & Key Indicators

Check Bausch Health Companies market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1B

EPS (TTM)

-2.95

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.70%

PE Ratio (TTM)

-1.92

Industry PE ratio

26.43

PEG Ratio

0.001387564578990302

EBITDA

5.4B

Revenue (TTM)

9.0B

Profit Margin

71.82%

Return On Equity TTM

88.77%

Bausch Health Companies Stock Valuation

Track how Bausch Health Companies P/E has moved over time to understand its valuation trends.

Bausch Health Companies in the last 5 years

  • Overview

  • Trends

Lowest (-64.60x)

December 31, 2024

Today (16.14x)

December 31, 2025

Industry (26.43x)

December 31, 2025

Highest (16.14x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 16.14x

Bausch Health Companies vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bausch Health Companies with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Neutral$2.1B-79.9%-1.9271.82%0.00%
StrongBuy$21.2B148.77%16.3686.14%0.00%
Buy$19.5B27.64%-47.0834.83%2.83%
Buy$40.1BNA18.7765.57%1.34%
Buy$29.5B-64.48%11.7570.87%2.93%

Stock Returns calculator for Bausch Health Companies Stock including INR - Dollar returns

The Bausch Health Companies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bausch Health Companies investment value today

Current value as on today

₹90,924

Returns

-₹9,076

(-9.08%)

Returns from Bausch Health Companies Stock

-₹16,196 (-16.2%)

Dollar Impact

₹7,120 (+7.12%)

Analyst Recommendation on Bausch Health Companies Stock

Based on 1 analysts

HOLD

0.00%

Buy

100.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'HOLD' rating for Bausch Health Companies. Average target price of $7.5

Bausch Health Companies Share Price Target

Get share price movements and forecasts by analysts on Bausch Health Companies.

What analysts predicted

24.8%UPSIDE

Target Price

$7.5

Current Price

$5.64

Analyzed by

1 Analysts

Target

$7.50

Bausch Health Companies target price $7.5, a slight upside of 24.8% compared to current price of $5.64. According to 1 analysts rating.

Indian Investors' Interest in Bausch Health Companies Stock

Search interest for Bausch Health Companies Stock has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-30% versus previous 30 day period

Bausch Health Companies Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
2,153
2,403
2,510
2,559
2,259
2,530
912
2,838
2,482
2,778
Gross Profit
1,513
1,684
1,814
1,832
1,558
1,766
1,580
1,789
1,519
1,807
Operating Income
281
389
318
558
276
444
619
730
512
754
EBITDA
606
716
647
853
588
912
2,520
1,024
802
1,028
Interest Expense
355
350
346
337
330
465
2,002
405
395
385
Depreciation
320
318
322
307
305
307
300
294
290
273
Income Before Tax
-69
48
-21
209
-47
140
215
56
-1,331
339
Income Tax Expense
8
49
71
111
39
12
36
161
75
85
Net Income
-64
10
-85
93
-58
148
179
-113
-1,399
251
Net Profit Margin
70.27%
70.08%
72.27%
71.59%
68.97%
69.80%
173.25%
63.02%
61.21%
65.04%

Bausch Health Companies Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
8,724
8,380
8,601
8,027
8,434
8,124
8,757
9,625
10,445
Gross Profit
6,176
6,029
6,251
5,778
6,040
5,760
6,198
6,843
6,361
Operating Income
102
-2,384
-73
676
1,210
1,370
963
1,546
2,223
EBITDA
3,413
350
1,850
2,425
3,260
2,878
2,202
2,822
3,452
Interest Expense
1,840
1,685
1,612
1,534
1,426
1,464
1,328
1,388
1,642
Depreciation
2,858
2,644
1,897
1,825
1,552
1,394
1,264
1,267
1,229
Income Before Tax
-1,741
-4,154
-1,837
-934
-1,024
-129
-390
167
373
Income Tax Expense
-4,145
-10
-54
-375
-87
83
221
239
251
Net Income
2,404
-4,148
-1,783
-559
-937
-212
-592
-46
159
Net Profit Margin
70.79%
71.95%
72.68%
71.98%
71.61%
70.90%
70.78%
71.10%
60.90%

Bausch Health Companies Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-77
-1
-92
98
-86
128
181
-113
-1,431
260
Operating Cash Flow
211
380
405
601
211
289
405
495
230
670
Investing Cash Flow
-73
-79
-102
-200
-130
-100
-83
-286
-139
-93
Financing Cash Flow
-340
-424
-189
85
-146
358
-719
-231
-100
-49
Change in Cash
-207
-132
127
451
-44
586
-403
-35
-13
526

Bausch Health Companies Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
2,404
-4,144
-1,783
-559
-937
-212
-611
-72
120
Operating Cash Flow
2,290
1,501
1,501
1,111
1,426
-728
1,032
1,597
1,378
Investing Cash Flow
2,887
-196
-419
-261
409
-303
-2,145
-454
-605
Financing Cash Flow
-4,963
-1,353
1,443
-2,294
-1,513
-474
1,475
-868
-709
Change in Cash
255
-74
2,521
-1,428
303
-1,528
371
239
64

Mutual Funds that own Bausch Health Companies Stock

Check out the Mutual Funds with significant holdings in Bausch Health Companies.

Funds
Holdings
Shares Held
VANGUARD STAR FUNDS
1.005959%
3762192
VANGUARD TAX-MANAGED FUNDS
0.654375%
2447301
DFA INVESTMENT DIMENSIONS GROUP INC
0.320086%
1197092
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS
0.306978%
1148072
TIAA-CREF Funds
0.227426%
850553

Global Institutional Holdings in Bausch Health Companies

Funds
Holdings
John Paulson
19.59%
Steven A. Tananbaum
9.27%
Vanguard
2.16%
Fidelity
1.28%
iShares
0.92%

Insights on Bausch Health Companies

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, BHC stock has moved up by 20.8%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -1.42B → 258.00M (in $), with an average increase of 651.6% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.52B → 2.85B (in $), with an average increase of 11.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 74.7% return, outperforming this stock by 91.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 77.4% return, outperforming this stock by 108.8%

About Bausch Health Companies

Bausch Health Companies Inc. is a global healthcare enterprise dedicated to the creation, production, and sale of a diverse array of pharmaceutical, medical device, and over-the-counter items. Its primary therapeutic focus areas include eye health, digestive system issues, and dermatological conditions. The company's operations are strategically organized into five key divisions: Bausch + Lomb, which specializes in vision care, surgical solutions, and ophthalmic pharmaceuticals; Salix, concentrating on gastroenterology products within the United States; International Rx, offering a broad portfolio encompassing Solta products, branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across numerous international markets in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East; Ortho Dermatologics, providing dermatological products in the U.S. and Solta medical aesthetic devices globally; and Diversified Products, covering pharmaceutical products in neurology and other therapeutic classes, alongside generic and dentistry items in the United States. Previously known as Valeant Pharmaceuticals International, Inc., the company adopted its current name in July 2018 and maintains its headquarters in Laval, Canada.
OrganisationBausch Health Companies
Headquarters2150 St. ElzEar Boulevard West, Laval, QC, H7L 4A8, CA
IndustryDrug Manufacturers - Specialty & Generic
CEOThomas J. Appio
E-voting on sharesClick here to vote

Key Management of Bausch Health Companies

Name

Title

Mr. Jean-Jacques Charhon

Executive VP & CFO

Mr. Cees Heiman

Senior Vice President of Europe & Canada

Mr. Thomas J. Appio

CEO & Director

Ms. Aimee J. Lenar

President of US Pharma

Mr. Mirza Dautbegovic

Executive VP & COO

Mr. Steven H. Lee

Senior VP, Controller & Chief Accounting Officer

Mr. Garen Sarafian

VP & Head of Investor Relations

Ms. Kathleen Fitzpatrick

Executive VP and Chief HR & Communications Officer

Ms. Jiny Kim M.B.A.

Senior Vice President of Solta Medical

Ms. Seana Carson

Executive VP & General Counsel

FAQs

What is Bausch Health Companies share price today?

Bausch Health Companies share price today is $5.64 as on at the close of the market. Bausch Health Companies share today touched a day high of $5.70 and a low of $5.55.

What is the 52 week high and 52 week low for Bausch Health Companies share?

Bausch Health Companies share touched a 52 week high of $8.00 on and a 52 week low of $4.33 on . Bausch Health Companies stock price today i.e. is closed at $5.64,which is 29.50% down from its 52 week high and 30.25% up from its 52 week low.

What is Bausch Health Companies's market capitalisation today?

Bausch Health Companies market capitalisation is $0.00T as on .

How to invest in Bausch Health Companies Stock (BHC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bausch Health Companies on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bausch Health Companies Shares that will get you 0.2660 shares as per Bausch Health Companies share price of $5.64 per share as on September 22, 2026 at 8:45 am IST.

What is the minimum amount required to buy Bausch Health Companies Stock (BHC) from India?

Indian investors can start investing in Bausch Health Companies (BHC) shares with as little as ₹95.805 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.05 in Bausch Health Companies stock (as per the Rupee-Dollar exchange rate as on ). Based on Bausch Health Companies share’s latest price of $5.64 as on September 22, 2026 at 8:45 am IST, you will get 1.7730 shares of Bausch Health Companies. Learn more about fractional shares .

What are the returns that Bausch Health Companies has given to Indian investors in the last 5 years?

Bausch Health Companies stock has given -79.9% share price returns and 30.09% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?